Hebei Changshan Biochem Pharma (300255) — Capital Reinvestment Ratio
Latest as of June 2025:
0.27x
Hebei Changshan Biochem Pharma (300255) has a Capital Reinvestment Ratio of 0.27x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥70.22 Million) in capital expenditures (CN¥18.63 Million). See cash generation quality of Hebei Changshan Biochem Pharma to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.27x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥70.22 Million
CNY
Capital Expenditures
CN¥18.63 Million
CNY
Data as of
Jun 2025
Most recent filing
Hebei Changshan Biochem Pharma Capital Reinvestment Ratio (2009–2024)
This chart tracks Hebei Changshan Biochem Pharma's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Hebei Changshan Biochem Pharma (2009–2024)
Year-by-year Capital Reinvestment Ratio for Hebei Changshan Biochem Pharma from 2009 to 2024. For live market cap and broader valuation context, see 300255 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 4.26x | CN¥56.22 Million | CN¥239.59 Million | ▼ -39.9% |
| 2023 | 7.10x | CN¥33.73 Million | CN¥239.32 Million | ▼ -94.9% |
| 2022 | 137.97x | CN¥3.13 Million | CN¥431.22 Million | ▲ +28.6% |
| 2021 | 107.29x | CN¥2.87 Million | CN¥308.08 Million | ▲ +13277.0% |
| 2018 | 0.80x | CN¥292.81 Million | CN¥234.85 Million | ▼ -17.8% |
| 2017 | 0.98x | CN¥162.28 Million | CN¥158.30 Million | ▲ +73.8% |
| 2016 | 0.56x | CN¥171.96 Million | CN¥96.52 Million | ▼ -68.6% |
| 2011 | 1.79x | CN¥17.04 Million | CN¥30.43 Million | ▲ +39.0% |
| 2010 | 1.28x | CN¥29.25 Million | CN¥37.56 Million | ▲ +29.3% |
| 2009 | 0.99x | CN¥24.21 Million | CN¥24.05 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow